Home/ Products/ Instruments/ EXENT® System/ EXENT Clinical Case Studies

The EXENT® System*
Clinical Case Studies

Access exclusive case studies and podcasts discussing mass spectrometry in monoclonal gammopathy assessment

Learn more about how the EXENT GAM Assay** enhances monoclonal gammopathy assessment through our clinical case study series, showcasing its effectiveness in detecting and monitoring monoclonal proteins and gain insights from experts through our curated podcasts, discussing the real-world application of mass spectrometry.

Choose a language: Click X to remove the current selection and choose a different language.
Results Found:
New perspectives on monoclonal proteins
Case Study
New perspectives on monoclonal proteins
Learn how the EXENT GAM Assay can offer insights into M-protein light chain glycosylation which has been described in the literature as a potent risk factor for progression to malignant plasma cell disorders.
New perspectives on monoclonal proteins
Podcast
New perspectives on monoclonal proteins
Resolving oligoclonal banding and therapeutic antibody interference BR-PT
Case Study
Resolving oligoclonal banding and therapeutic antibody interference BR-PT
Learn how the EXENT GAM Assay provides greater specificity than conventional methods and can enable clinicians to distinguish between M-protein, oligoclonal bands and therapeutic monoclonal antibodies.
Accurate diagnoses for patients with low-level M-protein BR-PT
Case Study
Accurate diagnoses for patients with low-level M-protein BR-PT
Discover how The EXENT GAM Assay is more sensitive than SPE and may detect M-proteins in NSMM and OSMM patients, allowing more confident detection of M-proteins at diagnosis and throughout the treatment pathway.
Sensitivity beyond complete response BR-PT
Case Study
Sensitivity beyond complete response BR-PT
Understand how the enhanced sensitivity of the EXENT GAM Assay may detect residual disease, even in those who have been assigned CR by the current response criteria.
New perspectives on monoclonal proteins BR-PT
Case Study
New perspectives on monoclonal proteins BR-PT
Learn how the EXENT GAM Assay can offer insights into M-protein light chain glycosylation which has been described in the literature as a potent risk factor for progression to malignant plasma cell disorders.
Sensitivity beyond complete response
Case Study
Sensitivity beyond complete response
Understand how the enhanced sensitivity of the EXENT GAM Assay may detect residual disease, even in those who have been assigned CR by the current response criteria.
Sensitivity beyond complete response
Podcast
Sensitivity beyond complete response
Resolving oligoclonal banding and therapeutic antibody interference
Case Study
Resolving oligoclonal banding and therapeutic antibody interference
Learn how the EXENT GAM Assay provides greater specificity than conventional methods and can enable clinicians to distinguish between M-protein, oligoclonal bands and therapeutic monoclonal antibodies.
Resolving oligoclonal banding and therapeutic antibody interference
Podcast
Resolving oligoclonal banding and therapeutic antibody interference
Accurate diagnoses for patients with low-level M-protein
Case Study
Accurate diagnoses for patients with low-level M-protein
Discover how The EXENT GAM Assay is more sensitive than SPE and may detect M-proteins in NSMM and OSMM patients, allowing more confident detection of M-proteins at diagnosis and throughout the treatment pathway.
Accurate diagnoses for patients with low-level M-protein
Podcast
Accurate diagnoses for patients with low-level M-protein
New perspectives on monoclonal proteins IT
Case Study
New perspectives on monoclonal proteins IT
Learn how the EXENT GAM Assay can offer insights into M-protein light chain glycosylation which has been described in the literature as a potent risk factor for progression to malignant plasma cell disorders.
New perspectives on monoclonal proteins DE
Case Study
New perspectives on monoclonal proteins DE
Learn how the EXENT GAM Assay can offer insights into M-protein light chain glycosylation which has been described in the literature as a potent risk factor for progression to malignant plasma cell disorders.
New perspectives on monoclonal proteins ES
Case Study
New perspectives on monoclonal proteins ES
Learn how the EXENT GAM Assay can offer insights into M-protein light chain glycosylation which has been described in the literature as a potent risk factor for progression to malignant plasma cell disorders.
Sensitivity beyond complete response IT
Case Study
Sensitivity beyond complete response IT
Understand how the enhanced sensitivity of the EXENT GAM Assay may detect residual disease, even in those who have been assigned CR by the current response criteria.
Sensitivity beyond complete response DE
Case Study
Sensitivity beyond complete response DE
Understand how the enhanced sensitivity of the EXENT GAM Assay may detect residual disease, even in those who have been assigned CR by the current response criteria.
Sensitivity beyond complete response ES
Case Study
Sensitivity beyond complete response ES
Understand how the enhanced sensitivity of the EXENT GAM Assay may detect residual disease, even in those who have been assigned CR by the current response criteria.
Resolving oligoclonal banding and therapeutic antibody interference IT
Case Study
Resolving oligoclonal banding and therapeutic antibody interference IT
Learn how the EXENT GAM Assay provides greater specificity than conventional methods and can enable clinicians to distinguish between M-protein, oligoclonal bands and therapeutic monoclonal antibodies.
Resolving oligoclonal banding and therapeutic antibody interference DE
Case Study
Resolving oligoclonal banding and therapeutic antibody interference DE
Learn how the EXENT GAM Assay provides greater specificity than conventional methods and can enable clinicians to distinguish between M-protein, oligoclonal bands and therapeutic monoclonal antibodies.
Resolving oligoclonal banding and therapeutic antibody interference ES
Case Study
Resolving oligoclonal banding and therapeutic antibody interference ES
Learn how the EXENT GAM Assay provides greater specificity than conventional methods and can enable clinicians to distinguish between M-protein, oligoclonal bands and therapeutic monoclonal antibodies.
Accurate diagnoses for patients with low-level M-protein IT
Case Study
Accurate diagnoses for patients with low-level M-protein IT
Discover how The EXENT GAM Assay is more sensitive than SPE and may detect M-proteins in NSMM and OSMM patients, allowing more confident detection of M-proteins at diagnosis and throughout the treatment pathway.
Accurate diagnoses for patients with low-level M-protein DE
Case Study
Accurate diagnoses for patients with low-level M-protein DE
Discover how The EXENT GAM Assay is more sensitive than SPE and may detect M-proteins in NSMM and OSMM patients, allowing more confident detection of M-proteins at diagnosis and throughout the treatment pathway.
Accurate diagnoses for patients with low-level M-protein ES
Case Study
Accurate diagnoses for patients with low-level M-protein ES
Discover how The EXENT GAM Assay is more sensitive than SPE and may detect M-proteins in NSMM and OSMM patients, allowing more confident detection of M-proteins at diagnosis and throughout the treatment pathway.

Interested in receiving future case studies direct to your inbox? 

Sign up for monthly clinical case studies!

Related Content

EXENT GAM Assay
Immunoassays
EXENT GAM Assay
The EXENT Analyser with the EXENT GAM Assay provides a sensitive and specific method for the assessment of M-proteins in patients with monoclonal gammopathies.
EXENT System
Instruments
EXENT System
The EXENT System is an automated solution that enables M-protein identification and measurement in serum with enhanced sensitivity beyond conventional methods

Product availability is subject to country specific regulatory requirements. Contact your local representative for availability in your country. This product is not commercially available in the USA or China. Future commercial availability cannot be guaranteed. EXENT is a registered trademark of The Binding Site Group Limited (Birmingham, UK).

*The EXENT® System combines EXENT® Analyser with the Immunoglobulin Isotypes (GAM) for the EXENT® Analyser.

**EXENT GAM Assay refers to Immunoglobulin Isotypes (GAM) for the EXENT® Analyser.

ThermoFisher Scientific
Our mission is to enable our customers to make the world healthier, cleaner and safer
© Thermo Fisher Scientific Inc. All Rights Reserved.